Trgovina Corbus Pharmaceuticals Holdings, Inc. - CRBP CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.398 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Corbus Pharmaceuticals Holdings Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 9.83 |
Odpri* | 9.86 |
Enoletna sprememba* | 3421.43% |
Dnevni razpon* | 8.641 - 9.95 |
Razpon 52 wk | 2.11-13.17 |
Povprečni obseg (10 dni) | 37.55K |
Povprečni obseg (3 meseci) | 9.49M |
Tržna kapitalizacija | 41.81M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 4.22M |
Prihodki | N/A |
EPS | -12.14 |
Dividenda (donosnost v %) | N/A |
Beta | 2.42 |
Datum naslednjega zaslužka | Aug 7, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
May 30, 2023 | 8.731 | -0.789 | -8.29% | 9.520 | 9.950 | 8.621 |
May 26, 2023 | 9.830 | -0.420 | -4.10% | 10.250 | 10.510 | 9.531 |
May 25, 2023 | 10.340 | -0.210 | -1.99% | 10.550 | 10.860 | 10.010 |
May 24, 2023 | 10.860 | 0.740 | 7.31% | 10.120 | 11.179 | 10.110 |
May 23, 2023 | 10.890 | 0.310 | 2.93% | 10.580 | 11.100 | 10.250 |
May 22, 2023 | 10.950 | 1.160 | 11.85% | 9.790 | 11.269 | 9.790 |
May 19, 2023 | 10.530 | 1.039 | 10.95% | 9.491 | 10.750 | 9.490 |
May 18, 2023 | 9.631 | -0.349 | -3.50% | 9.980 | 10.210 | 9.631 |
May 17, 2023 | 10.080 | 0.310 | 3.17% | 9.770 | 10.640 | 9.760 |
May 16, 2023 | 10.370 | 0.300 | 2.98% | 10.070 | 10.890 | 10.070 |
May 15, 2023 | 10.240 | 0.789 | 8.35% | 9.451 | 10.530 | 9.111 |
May 12, 2023 | 9.641 | 0.230 | 2.44% | 9.411 | 9.791 | 8.971 |
May 11, 2023 | 9.281 | 0.360 | 4.04% | 8.921 | 9.581 | 8.681 |
May 10, 2023 | 9.201 | -0.290 | -3.06% | 9.491 | 10.080 | 9.101 |
May 9, 2023 | 8.721 | -0.560 | -6.03% | 9.281 | 9.541 | 8.471 |
May 8, 2023 | 9.501 | -0.189 | -1.95% | 9.690 | 10.130 | 9.121 |
May 5, 2023 | 10.050 | 1.679 | 20.06% | 8.371 | 10.220 | 8.371 |
May 4, 2023 | 8.422 | 0.320 | 3.95% | 8.102 | 8.841 | 8.062 |
May 3, 2023 | 8.312 | 0.610 | 7.92% | 7.702 | 9.291 | 7.492 |
May 2, 2023 | 7.842 | -0.100 | -1.26% | 7.942 | 8.492 | 7.702 |
Corbus Pharmaceuticals Holdings, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Monday, August 7, 2023 | ||
Čas (UTC) (UTC) 12:00 | Država US
| Dogodek Q2 2023 Corbus Pharmaceuticals Holdings Inc Earnings Release Q2 2023 Corbus Pharmaceuticals Holdings Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Čas (UTC) (UTC) 13:05 | Država US
| Dogodek Q3 2023 Corbus Pharmaceuticals Holdings Inc Earnings Release Q3 2023 Corbus Pharmaceuticals Holdings Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0.88171 | 3.93723 | 36.1436 | 4.82227 |
Prihodki | 0 | 0.88171 | 3.93723 | 36.1436 | 4.82227 |
Celotni odhodki iz poslovanja | 39.8354 | 56.8707 | 126.747 | 113.248 | 61.57 |
Celotna prodaja/splošni/upravni stroški Odhodki | 18.6986 | 20.4254 | 28.4802 | 23.6434 | 12.956 |
Raziskave in razvoj | 16.1368 | 36.4453 | 98.2672 | 89.6048 | 48.614 |
Prihodki iz poslovanja | -39.8354 | -55.989 | -122.81 | -77.1046 | -56.7477 |
Prihodki (odhodki) od obresti, neto Neoperativni | -2.46268 | -1.5514 | -1.72936 | 1.06902 | 1.07557 |
Čisti dobiček pred obdavčitvijo | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Čisti dobiček po davkih | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Čisti dobiček pred dodatnimi postavkami | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Čisti dobiček | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Popravljen čisti dobiček | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Popravljene ponderirane povprečne delnice | 4.17068 | 4.09967 | 2.60444 | 2.12976 | 1.8998 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -10.1535 | -11.1327 | -42.7229 | -33.5501 | -29.3042 |
Popravljen normalizirani dobiček na enoto čistega dobička | -8.95464 | -10.9849 | -42.7229 | -33.5501 | -29.3042 |
Skupaj izredne postavke | |||||
Drugo, neto | -0.04877 | 11.9 | 13.2702 | 4.58184 | |
Nenavadni odhodki (prihodki) | 5 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 17.297 | 10.7968 | 8.18146 | 12.34 | 8.51716 |
Celotna prodaja/splošni/upravni stroški Odhodki | 3.90868 | 4.55406 | 4.07327 | 4.84037 | 5.23092 |
Raziskave in razvoj | 13.3883 | 6.24276 | 4.10819 | 2.49964 | 3.28624 |
Prihodki iz poslovanja | -17.297 | -10.7968 | -8.18146 | -12.34 | -8.51716 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.67729 | -0.35778 | -0.67798 | -0.7002 | -0.72673 |
Drugo, neto | 0.22951 | 0.27555 | 0.07771 | -0.20868 | -0.19335 |
Čisti dobiček pred obdavčitvijo | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Čisti dobiček po davkih | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Čisti dobiček pred dodatnimi postavkami | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Čisti dobiček | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Popravljen čisti dobiček | -17.7448 | -10.8791 | -8.78172 | -13.2489 | -9.43724 |
Popravljene ponderirane povprečne delnice | 4.18156 | 4.15711 | 4.17561 | 4.1752 | 4.17477 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -4.24359 | -2.61698 | -2.1031 | -3.17324 | -2.26054 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -4.24359 | -2.61698 | -2.1031 | -1.97569 | -2.26054 |
Nenavadni odhodki (prihodki) | 0 | 0 | 5 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 60.1811 | 100.205 | 92.0746 | 38.1547 | 44.2403 |
Denarna sredstva in kratkoročne naložbe | 59.197 | 97.6471 | 85.4334 | 31.7487 | 41.7485 |
Cash | 3.80516 | 6.75159 | 1.82578 | 0.88412 | 0.80894 |
Denarna sredstva in ustrezniki | 13.1976 | 18.255 | 83.6077 | 30.8646 | 40.9395 |
Celotne terjatve, neto | 0 | 2.57833 | 2.68107 | ||
Prepaid Expenses | 0.79162 | 2.36501 | 3.71286 | 3.72493 | 2.49184 |
Other Current Assets, Total | 0.19248 | 0.19248 | 0.35 | 0 | |
Total Assets | 66.3119 | 107.73 | 102.295 | 49.1425 | 46.9893 |
Property/Plant/Equipment, Total - Net | 5.49807 | 7.00181 | 9.31636 | 10.9029 | 2.70521 |
Property/Plant/Equipment, Total - Gross | 8.59129 | 9.37405 | 11.6652 | 12.3088 | 3.37179 |
Accumulated Depreciation, Total | -3.09322 | -2.37224 | -2.34884 | -1.40596 | -0.66658 |
Other Long Term Assets, Total | 0.63277 | 0.52381 | 0.90394 | 0.08497 | 0.04382 |
Total Current Liabilities | 12.6399 | 17.0075 | 31.8978 | 34.8877 | 18.0893 |
Accounts Payable | 2.17396 | 1.78228 | 7.38118 | 11.0914 | 6.34534 |
Accrued Expenses | 7.28012 | 11.2303 | 23.0095 | 23.0437 | 9.85119 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3.14899 | 3.86128 | 0.71016 | 0.75266 | 0.39431 |
Other Current Liabilities, Total | 0.03687 | 0.13371 | 0.797 | 0 | 1.4985 |
Total Liabilities | 33.3219 | 38.6222 | 57.02 | 42.9849 | 19.4652 |
Total Long Term Debt | 15.9844 | 15.6363 | 18.029 | 0 | 0 |
Other Liabilities, Total | 4.69756 | 5.97842 | 7.09317 | 8.09723 | 1.37589 |
Total Equity | 32.99 | 69.108 | 45.2749 | 6.15757 | 27.5241 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.00042 | 0.01252 | 0.00989 | 0.00647 | 0.00573 |
Additional Paid-In Capital | 425.196 | 418.892 | 349.358 | 198.975 | 148.889 |
Retained Earnings (Accumulated Deficit) | -392.081 | -349.734 | -304.093 | -192.824 | -121.37 |
Total Liabilities & Shareholders’ Equity | 66.3119 | 107.73 | 102.295 | 49.1425 | 46.9893 |
Total Common Shares Outstanding | 4.1713 | 4.17395 | 3.29476 | 2.15555 | 1.90806 |
Accounts Receivable - Trade, Net | 0 | 1.6183 | 2.68107 | ||
Long Term Debt | 15.9844 | 15.6363 | 18.029 | ||
Kratkoročne naložbe | 42.1943 | 72.6405 | |||
Other Equity, Total | -0.12609 | -0.06245 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 45.865 | 60.1811 | 67.3478 | 75.238 | 88.4756 |
Denarna sredstva in kratkoročne naložbe | 44.227 | 59.197 | 66.2292 | 73.3032 | 86.1212 |
Cash | 2.89716 | 3.80516 | 3.80611 | 3.98804 | 12.9421 |
Denarna sredstva in ustrezniki | 4.42728 | 13.1976 | 8.63754 | 21.7826 | 44.0842 |
Kratkoročne naložbe | 36.9026 | 42.1943 | 53.7856 | 47.5326 | 29.0949 |
Celotne terjatve, neto | |||||
Accounts Receivable - Trade, Net | |||||
Prepaid Expenses | 1.44552 | 0.79162 | 0.92616 | 1.74227 | 2.16186 |
Other Current Assets, Total | 0.19248 | 0.19248 | 0.19248 | 0.19248 | 0.19248 |
Total Assets | 51.6453 | 66.3119 | 73.8306 | 82.0666 | 95.6751 |
Property/Plant/Equipment, Total - Net | 5.12041 | 5.49807 | 5.87229 | 6.24708 | 6.6468 |
Property/Plant/Equipment, Total - Gross | 8.39551 | 8.59129 | 8.78111 | 8.96512 | 9.21476 |
Accumulated Depreciation, Total | -3.27509 | -3.09322 | -2.90883 | -2.71803 | -2.56796 |
Other Long Term Assets, Total | 0.65986 | 0.63277 | 0.61048 | 0.58159 | 0.5527 |
Total Current Liabilities | 14.3589 | 12.6399 | 17.4692 | 15.6298 | 15.1177 |
Accounts Payable | 1.32299 | 2.17396 | 1.37422 | 1.98662 | 2.69681 |
Accrued Expenses | 7.78697 | 7.28012 | 6.07764 | 5.92389 | 6.66826 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 5.21212 | 3.14899 | 9.88364 | 7.58555 | 5.61892 |
Other Current Liabilities, Total | 0.03687 | 0.03687 | 0.13371 | 0.13371 | 0.13371 |
Total Liabilities | 35.1863 | 33.3219 | 31.8845 | 32.5968 | 34.5198 |
Total Long Term Debt | 13.9724 | 15.9844 | 9.38585 | 11.6122 | 13.7284 |
Long Term Debt | 13.9724 | 15.9844 | 9.38585 | 11.6122 | 13.7284 |
Other Liabilities, Total | 6.85501 | 4.69756 | 5.02944 | 5.35477 | 5.67369 |
Total Equity | 16.459 | 32.99 | 41.9461 | 49.4699 | 61.1553 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.00042 | 0.00042 | 0.01253 | 0.01253 | 0.01253 |
Additional Paid-In Capital | 426.352 | 425.196 | 423.342 | 421.997 | 420.483 |
Retained Earnings (Accumulated Deficit) | -409.825 | -392.081 | -381.202 | -372.42 | -359.171 |
Other Equity, Total | -0.06847 | -0.12609 | -0.20687 | -0.11932 | -0.16969 |
Total Liabilities & Shareholders’ Equity | 51.6453 | 66.3119 | 73.8306 | 82.0666 | 95.6751 |
Total Common Shares Outstanding | 4.21513 | 4.1713 | 4.17561 | 4.1752 | 4.17478 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -42.3469 | -45.6404 | -111.269 | -71.4537 | -55.6721 |
Denarna sredstva iz poslovanja | -37.5444 | -48.1837 | -99.6857 | -45.7207 | -30.0673 |
Denarna sredstva iz poslovanja | 0.763 | 0.99982 | 1.12385 | 0.73938 | 0.49394 |
Nedenarne postavke | 8.06298 | 12.1534 | 13.6647 | 12.5179 | 8.10229 |
Denarna sredstva Plačane obresti | 1.96958 | 1.74088 | 0.62915 | 0.02945 | 0.01044 |
Spremembe v obratnem kapitalu | -4.02351 | -15.6965 | -3.20492 | 12.4757 | 17.0086 |
Denarna sredstva pri naložbenju | 30.0741 | -73.4165 | -0.48449 | -2.74254 | -2.30042 |
Kapitalski izdatki | -0.01345 | -0.05417 | -0.48449 | -2.74254 | -2.30042 |
Denarna sredstva pri financiranju | -0.53362 | 60.8234 | 154.875 | 38.4635 | 11.4197 |
Postavke denarnega toka pri financiranju | 0 | -1.82044 | -6.03942 | -2.57155 | -0.69018 |
Izdaja (odplačilo) delnic, neto | 0 | 62.5861 | 142.201 | 40.6771 | 12.0527 |
Izdaja (odplačilo) dolga, neto | -0.53362 | 0.05778 | 18.7135 | 0.35798 | 0.05719 |
Neto sprememba denarnih sredstev | -8.00392 | -60.7768 | 54.7047 | -9.99978 | -20.948 |
Celotne druge postavke denarnih tokov pri naložbenju | 30.0876 | -73.3624 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.7448 | -42.3469 | -31.4678 | -22.6861 | -9.43724 |
Cash From Operating Activities | -15.115 | -37.5444 | -30.0895 | -22.8444 | -10.6153 |
Cash From Operating Activities | 0.18187 | 0.763 | 0.5786 | 0.3878 | 0.19572 |
Non-Cash Items | 1.22002 | 8.06298 | 6.78652 | 5.24585 | 2.75334 |
Cash Interest Paid | 0.64146 | 1.96958 | 1.40721 | 0.88743 | 0.431 |
Changes in Working Capital | 1.22795 | -4.02351 | -5.98672 | -5.79193 | -4.12716 |
Cash From Investing Activities | 5.5497 | 30.0741 | 18.2944 | 24.2657 | 42.9622 |
Capital Expenditures | 0 | -0.01345 | -0.01345 | -0.01345 | -0.01345 |
Other Investing Cash Flow Items, Total | 5.5497 | 30.0876 | 18.3078 | 24.2791 | 42.9756 |
Cash From Financing Activities | -0.11301 | -0.53362 | -0.76794 | -0.65723 | -0.32713 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0.03706 | 0 | 0 | 0 | 0 |
Issuance (Retirement) of Debt, Net | -0.15007 | -0.53362 | -0.76794 | -0.65723 | -0.32713 |
Net Change in Cash | -9.67828 | -8.00392 | -12.563 | 0.76403 | 32.0197 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Ikarian Capital LLC | Hedge Fund | 4.5612 | 192260 | 179021 | 2023-03-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.2574 | 179455 | 44485 | 2023-03-31 | LOW |
Sio Capital Management, LLC | Hedge Fund | 3.5586 | 150000 | 150000 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.6732 | 70528 | -6360 | 2023-03-31 | LOW |
Boothbay Fund Management, LLC | Investment Advisor/Hedge Fund | 0.9009 | 37976 | 36645 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7797 | 32865 | -4 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.3246 | 13681 | 12633 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3127 | 13179 | -5 | 2023-03-31 | LOW |
Virtu Americas LLC | Research Firm | 0.2391 | 10077 | 10077 | 2023-03-31 | HIGH |
Moran (Sean F) | Individual Investor | 0.1576 | 6642 | -1 | 2023-03-24 | LOW |
Tekla Capital Management LLC | Investment Advisor | 0.122 | 5143 | -1 | 2023-03-31 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.1149 | 4844 | 3845 | 2023-03-31 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 0.0827 | 3487 | 900 | 2023-03-31 | MED |
Fidelity Management & Research Company LLC | Investment Advisor | 0.0798 | 3365 | -7748 | 2023-03-31 | LOW |
Cohen (Yuval) | Individual Investor | 0.0777 | 3274 | -1 | 2023-03-24 | LOW |
Group One Trading, L.P. | Research Firm | 0.0537 | 2265 | -2049 | 2023-03-31 | HIGH |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.0445 | 1876 | 1876 | 2023-03-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.0386 | 1629 | -2 | 2023-03-31 | LOW |
Catlin (Avery W) | Individual Investor | 0.0372 | 1567 | 0 | 2023-03-24 | LOW |
Envestnet Asset Management, Inc. | Investment Advisor | 0.0269 | 1133 | 1133 | 2022-12-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Corbus Pharmaceuticals Company profile
O družbi Corbus Pharmaceuticals Holdings, Inc.
Družba Corbus Pharmaceuticals Holdings, Inc., se osredotoča na razvoj imunskih modulatorjev, ki se uporabljajo pri bolezenskih stanjih od imunoonkologije do fibroze. Družba pripravlja antiintegrinska monoklonska protitelesa, ki blokirajo aktivacijo TGFβ, in majhne molekule, ki aktivirajo ali zavirajo endokanabinoidni sistem. Družba pripravlja protiintegrinska monoklonska protitelesa (mAbs), kanabinoidni receptor tipa 1 (CB1) in zdravilo Lenabasum. mAbs je namenjen zdravljenju raka in fibroze, ki zavira aktivacijo transformacijskega rastnega dejavnika β (TGFβ). CRB-601 je antiαvβ8 mAb, ki ga razvija kot potencialno zdravilo za solidne tumorje v kombinaciji z obstoječimi terapijami, vključno z zaviralci kontrolnih točk. Kanabinoidni receptor tipa 1 (CB1) je inverzni agonist, namenjen zdravljenju debelosti in povezanih presnovnih bolezni. Lenabasum je nova, sintetična, peroralna molekula, ki selektivno aktivira kanabinoidni receptor tipa 2 (CB2).
Industry: | Bio Therapeutic Drugs |
500 River Ridge Drive
NORWOOD
MASSACHUSETTS 02062
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com